Evidence map›Paper›PMID 42310732›Full record

ArticleRespiratory research2026

Design of a randomized controlled trial comparing hybrid care with standard care for people with pulmonary fibrosis.

Delian E Hofman, Catharina C Moor, Frouke F van Beek, Adriane D M Vorselaars, Maria J Overbeek, Kelly van Doorn-Hogervorst, Linda A A Moonen, Jan van der Maten, Paul Bresser, Daan W Loth and 6 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06883448 (The SUITS Study), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06883448 narecruitingnot on this map

The SUITS Study: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

TypeinterventionalSponsorErasmus Medical CenterRan2024 to 2027Enrolled220ConditionsPulmonary Fibrosis, Interstitial Lung Disease (ILD)ArmsHome monitoring care
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Delian E HofmanCentre of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus Medical Centre, Dr. Molewaterplein 40, Rotterdam, 3015 GD, the Netherlands.
Catharina C MoorCentre of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus Medical Centre, Dr. Molewaterplein 40, Rotterdam, 3015 GD, the Netherlands.
Frouke F van BeekInterstitial Lung Diseases Centre of Excellence, Department of Pulmonology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
Adriane D M VorselaarsInterstitial Lung Diseases Centre of Excellence, Department of Pulmonology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
Maria J OverbeekDepartment of Respiratory Medicine, Haaglanden Medical Center, The Hague, the Netherlands.
Kelly van Doorn-HogervorstDepartment of Respiratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Linda A A MoonenDepartment of Respiratory Medicine, Rijnstate Hospital, Arnhem, the Netherlands.
Jan van der MatenDepartment of Respiratory Medicine, Frisius Medical Center, Leeuwarden, the Netherlands.
Paul BresserDepartment of Respiratory Medicine, OLVG Amsterdam, Amsterdam, the Netherlands.
Daan W LothDepartment of Respiratory Medicine, Amphia, Breda, the Netherlands.
Eveline SchakenraadDepartment of Respiratory Medicine, Catharina Hospital, Eindhoven, the Netherlands.
René KerstensOrion Statistical Consulting BV, Hilvarenbeek, the Netherlands.
Pieter van der Wal, Ridderkerk, the Netherlands.
Marleen de MulErasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
Rémy L M MostardDepartment of Respiratory Medicine, Zuyderland Medical Centre, Heerlen/Sittard-Geleen, the Netherlands.
Marlies S WijsenbeekCentre of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus Medical Centre, Dr. Molewaterplein 40, Rotterdam, 3015 GD, the Netherlands. m.wijsenbeek-lourens@erasmusmc.nl.

Funding

ZonMw (the Netherlands Organisation for Health Research and Development) 10140292110006
6 · The paper itself

Abstract

backgroundPeople with pulmonary fibrosis (PF) live with persistent dyspnea, chronic cough, and fatigue. Symptoms that impair their exercise capacity and quality of life. The need for frequent outpatient clinic visits to evaluate disease progression and treatment response can impose a substantial burden on people with PF. Online home monitoring has the potential to replace some of these visits. However, structural implementation and evidence on its impact on patient outcomes are lacking. Here, we describe the design of the SUITS study, a multicenter randomized controlled trial (RCT) which aims to evaluate the impact of partly replacing conventional outpatient clinic visits with home monitoring and video consultations on clinically relevant patient outcomes and efficiency of healthcare systems.

methodsPatients will be randomized to either standard care (3-monthly outpatient clinic visits) or hybrid care. Hybrid care consists of a home monitoring program and video consultations that alternately replace outpatient clinic visits. In an online application, patients perform weekly home spirometry and pulse-oximetry measurements, fill out patient reported outcome measures (PROMs) on a regular basis, and have access to an information library with disease specific information. The primary endpoint of this RCT is the change in patient self-management from baseline to 12 months, assessed with the validated patient activation measure (PAM). DISCUSSION: In light of the insufficient implementation of a hybrid care pathway for people with PF, there is pressing need for a trial to confirm if partly replacing outpatient clinic visits with home monitoring and video consultations is both feasible and effective. REGISTRATION DETAILS: Clinicaltrials.Gov: NCT06883448, date of registration: 13-03-2025. The study was retrospectively registered. No changes were made to the IRB approved study protocol (version 1, 11-01-2024) prior to registration at ClinicalTrials.gov.

Indexed as

Pulmonary FibrosisFemaleHumansMaleMulticenter Studies as TopicQuality of LifeRandomized Controlled Trials as TopicRemote Patient MonitoringeHealthPulmonary fibrosisRemote monitoringSelf-managementValue-based healthcare

Identifiers

PMID42310732
PMCPMC13508517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.